RxDoctor Payments Data

Wilfrido Benitez, MD

Family Medicine · Hialeah, FLNPI 1629026695

Payments from drug & device makers

$2,024,029in general payments, 2019–2025

Across 495 payments — averaging $4088.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$1M
  • Bausch Health US, LLC$518K
  • GSK$195K
  • Avanir Pharmaceuticals, Inc.$131K
  • Currax Pharmaceuticals LLC$71K
  • Braintree Laboratories, Inc.$41K
  • plus $60K from 14 others

What the payments were for

  • Food & beverage$3,166100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,024,029 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$13,409
Medicare patients
25
Services billed
151

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban33$44,018
JardianceEmpagliflozin26$38,639
FarxigaDapagliflozin Propanediol25$34,152
JanuviaSitagliptin Phosphate21$30,663
XareltoRivaroxaban18$28,905
MounjaroTirzepatide22$27,771
TrulicityDulaglutide20$25,596
EntrestoSacubitril/Valsartan13$22,893
OzempicSemaglutide15$14,273
NamzaricMemantine Hcl/Donepezil Hcl14$13,310
SymbicortBudesonide/Formoterol Fumarate27$7,378
VascepaIcosapent Ethyl16$5,605
Memantine Hcl ErMemantine Hcl16$4,101
Wixela InhubFluticasone Propion/Salmeterol18$2,198
SynthroidLevothyroxine Sodium13$1,616

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Humulin 70-30$554$54,41554 claims
PfizerEliquis$1,006,812$44,01833 claims
Boehringer IngelheimJardiance$125$38,63926 claims
Johnson & JohnsonXarelto$668$28,90518 claims
NovartisEntresto$351$22,89313 claims
Novo NordiskOzempic$233$14,27315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Hialeah

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →